Skip to main content
TWLO
NYSE Technology

Twilio Lifts FY26 Revenue Growth Target to 20% After Q3 Beat

Tom Rudovsky · Reported by Wiseek News
More coverage: Internet Stocks · Communication
Sentiment info
Positive
Importance info
8
Price
$241.283
Mkt Cap
$37.15B
52W Low
$105
52W High
$308.4
52W Position info
130% above low
Off High info
22% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

TWLO has more than doubled off its 52-week low of $105.

Summary

Twilio raised FY26 revenue growth guidance to 20% from 18%-18.5% and lifted non-GAAP operating income to $1.19B-$1.20B from $1.135B-$1.155B, alongside Q3 2026 results that included revenue of $1.56B, net income of $161.2M, EPS of $1.00 and adjusted EPS of $1.65. Free cash flow for the year is now guided to $1.19B-$1.20B, and Q4 revenue is pegged at $1.595B-$1.605B with non-GAAP EPS of $1.48-$1.53. The Q4 revenue range implies 17%-17.5% reported growth but only 11%-12% organic, so the headline number leans on acquisitions and the organic trend is the part that matters. This builds on the August 6 8-K, when Twilio posted $1.5B in Q2 revenue with 17% organic growth and already raised full-year guidance; the company is now raising again two quarters running. Buybacks totaled $127.2M in Q3 with roughly $700M left on the authorization, which supports per-share numbers. The stock fell 11% on October 16 to $243.62 and sits near $241 now, so the raised outlook lands into a beaten-down tape and gives traders a concrete reason to re-examine the organic growth story.

Updates

  1. · SEC 8-K — Twilio's Q3 GAAP operating income rose 263% to $148.6M and non-GAAP operating income rose 39% to $325.7M; Q4 non-GAAP operating income is guided to $300M-$310M.

    • Q3 Profitability — Q3 revenue was $1,559,536 thousand versus $1,300,402 thousand prior year. GAAP gross profit was $760,530 thousand, up 20%, and non-GAAP gross profit $767,800 thousand, up 18%. GAAP operating margin was 10% versus 3%; non-GAAP 21% versus 18%.
    • Q3 Earnings — Q3 GAAP net income attributable to common stockholders was $161,157 thousand versus $37,248 thousand prior year; non-GAAP $266,887 thousand versus $198,258 thousand. GAAP diluted EPS was $1.00 versus $0.23; non-GAAP diluted EPS $1.65 versus $1.25.
    • Organic Growth — Q3 organic revenue growth was 16% Y/Y, with organic revenue of $1,504,648 thousand after excluding $53,128 thousand A2P revenue and $1,760 thousand acquisition revenue. FY26 organic revenue growth outlook was raised to 15% Y/Y from 13%-13.5%. Dollar-Based Net Expansion Rate was 114% versus 109%.
    • Cash Flow — Q3 net cash provided by operating activities was $389,164 thousand and free cash flow $369,629 thousand, versus $263,563 thousand and $247,516 thousand prior year. Nine-month 2026 operating cash flow was $914,755 thousand versus $731,689 thousand. Q3 operating cash flow margin was 25% versus 20%.
    • Buybacks — The share repurchase program is authorized up to $2.0 billion, expiring December 31, 2027; approximately $1.3 billion is completed and approximately $700 million remains. Q3 repurchases were $127.2 million; nine-month repurchases were $448,296 thousand versus $670,472 thousand.
    • Q4 Guidance — Q4 non-GAAP gross profit is expected similar to the organic revenue growth range of 11%-12%. Q4 non-GAAP diluted EPS guidance is based on 163 million non-GAAP weighted average diluted shares outstanding.
    • Nine-Month Items — Nine-month 2026 net income of $1,318,505 thousand included a $937,077 thousand tax benefit from release of a valuation allowance. Capitalized software development costs were $47,968 thousand; purchases of long-lived assets $12,168 thousand. Net cash used in financing activities was $411,258 thousand; investing activities $124,500 thousand.
    • Stock Compensation — Q3 2026 stock-based compensation was $153,916 thousand, or 9.9% of revenue, versus 12.2% prior year. By function: R&D $79,204 thousand; sales and marketing $35,313 thousand; G&A $36,151 thousand.
    • Non-GAAP Adjustments — Q3 non-GAAP adjustments include acquisition related expenses of $22 thousand and restructuring costs of $46 thousand. The non-GAAP tax adjustment was $(97,304) thousand; charitable contributions $5,527 thousand; accretion of debt discount $444 thousand. FY26 non-GAAP gross profit growth is expected similar to the 15% organic revenue growth range.
    All 34 details
    • Q3 organic revenue growth 16% Y/Y; organic revenue $1,504,648 thousand after excluding $53,128 thousand A2P revenue and $1,760 thousand acquisition revenue.
    • FY26 organic revenue growth outlook raised to 15% Y/Y from 13%-13.5% previously.
    • Q3 GAAP gross profit $760,530 thousand, up 20%; non-GAAP gross profit $767,800 thousand, up 18%.
    • Q3 GAAP net income attributable to common stockholders $161,157 thousand versus $37,248 thousand prior year; non-GAAP $266,887 thousand versus $198,258 thousand.
    • Q3 GAAP diluted EPS $1.00 versus $0.23 prior year; non-GAAP diluted EPS $1.65 versus $1.25.
    • Q3 net cash provided by operating activities $389,164 thousand and free cash flow $369,629 thousand, versus $263,563 thousand and $247,516 thousand prior year.
    • Dollar-Based Net Expansion Rate 114% in Q3 2026 versus 109% in Q3 2025.
    • Share repurchase program authorized up to $2.0 billion, expiring December 31, 2027; approximately $1.3 billion completed, approximately $700 million remaining.
    • Q4 non-GAAP gross profit expected similar to organic revenue growth range of 11%-12%.
    • Q4 non-GAAP diluted EPS guidance based on 163 million non-GAAP weighted average diluted shares outstanding.
    • Nine-month 2026 net income $1,318,505 thousand included $937,077 thousand tax benefit related to release of valuation allowance.
    • Nine-month 2026 cash flow included $32,771 thousand impairment loss on prepaid assets and $77,058 thousand share of losses from equity method investment.
    • Q3 2026 stock-based compensation $153,916 thousand, or 9.9% of revenue, versus 12.2% prior year.
    • Q3 2026 share repurchases $127.2 million; nine-month repurchases $448,296 thousand.
    • Q3 GAAP operating margin 10% versus 3% prior year; non-GAAP operating margin 21% versus 18%.
    • Q3 GAAP gross margin 49% versus 49%; non-GAAP gross margin 49% versus 50%.
    • Q3 GAAP diluted EPS based on 161,746,027 weighted average shares versus 159,209,951 prior year.
    • Q3 basic EPS $1.04 versus $0.24; basic weighted average shares 154,378,183 versus 153,119,639.
    • Q3 revenue $1,559,536 thousand versus $1,300,402 thousand prior year.
    • Q3 cost of revenue $799,006 thousand; R&D $280,367 thousand; sales and marketing $216,646 thousand; G&A $114,887 thousand.
    • Q3 income before benefit from income taxes $139,129 thousand; benefit from income taxes $22,028 thousand.
    • Q3 share of losses from equity method investment $25,489 thousand; other income, net $15,988 thousand.
    • Nine-month 2026 net cash provided by operating activities $914,755 thousand versus $731,689 thousand.
    • Nine-month 2026 capitalized software development costs $47,968 thousand; purchases of long-lived assets $12,168 thousand.
    • Nine-month 2026 stock-based compensation $432,339 thousand; depreciation and amortization $91,414 thousand.
    • Nine-month 2026 impairment of capitalized internal-use software development costs $13,957 thousand.
    • Nine-month 2026 net cash used in financing activities $411,258 thousand; investing activities $124,500 thousand.
    • Q3 stock-based compensation by function: R&D $79,204 thousand; sales and marketing $35,313 thousand; G&A $36,151 thousand.
    • Q3 non-GAAP adjustments include acquisition related expenses $22 thousand and restructuring costs $46 thousand.
    • Q3 non-GAAP tax adjustment $(97,304) thousand; charitable contributions $5,527 thousand; accretion of debt discount $444 thousand.
    • FY26 non-GAAP gross profit growth expected similar to organic revenue growth range of 15%.
    • Q3 operating cash flow margin 25% versus 20%; free cash flow margin 24% versus 19%.
    • Nine-month 2026 repurchases of Class A common stock and related costs $448,296 thousand versus $670,472 thousand.
    • Nine-month 2026 proceeds from option exercises and ESPP $37,293 thousand; equity awards withheld for taxes $62 thousand.

At the time of this announcement, TWLO was trading at $241.28 on NYSE in the Technology sector, with a market capitalization of approximately $37.1B. The 52-week trading range was $105.00 to $308.40. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

TWLO - Latest Insights

TWLO
Oct 30, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $205.00
Real-time Price: $195.01 info
Change: -$9.99 (-5%) info
Market Cap: $30.317B info
TWLO
Oct 30, 2026, 8:32 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $183.12
Real-time Price: $195.01 info
Change: +$11.89 (+6%) info
Market Cap: $30.317B info
TWLO
Oct 16, 2026, 1:14 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $243.09
Real-time Price: $195.01 info
Change: -$48.08 (-20%) info
Market Cap: $30.317B info
TWLO
Aug 12, 2026, 8:16 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $245.50
Real-time Price: $195.01 info
Change: -$50.49 (-21%) info
Market Cap: $30.317B info
TWLO
Aug 07, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $241.99
Real-time Price: $195.01 info
Change: -$46.98 (-19%) info
Market Cap: $30.317B info